Cargando…
Implications of True and Perceived Treatment Burden on Cardiovascular Medication Use
Background: Clinical decisions require weighing possible risks and benefits, which are often based on the provider’s sense of treatment burden. Patients often have a different view of how heavily treatment burden should be weighted. Objective: To examine how much small variations in patient treatmen...
Autores principales: | Sussman, Jeremy B., Schell, Greggory J., Lavieri, Mariel S., Hayward, Rodney A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124940/ https://www.ncbi.nlm.nih.gov/pubmed/30288433 http://dx.doi.org/10.1177/2381468317735306 |
Ejemplares similares
-
Data-Driven Markov Decision Process Approximations for Personalized
Hypertension Treatment Planning
por: Schell, Greggory J., et al.
Publicado: (2016) -
Filtering data from the collaborative initial glaucoma treatment study for improved identification of glaucoma progression
por: Schell, Greggory J, et al.
Publicado: (2013) -
Providing clinicians with a patient’s 10-year cardiovascular risk improves their statin prescribing: a true experiment using clinical vignettes
por: Sekaran, Nishant K, et al.
Publicado: (2013) -
An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials
por: Sussman, Jeremy B, et al.
Publicado: (2010) -
Black-White Cardiovascular Disease Disparities After Target-Based
Versus Personalized Benefit–Based Lipid and Blood Pressure
Treatment
por: Basu, Sanjay, et al.
Publicado: (2017)